BLUE Similar Chart Price Prediction
The price of BLUE is predicted to go up 4%, based on the high correlation periods with GIC. The similarity of these two price pattern on the periods is 91.92%.
BLUE
GIC
Up: 4%Similarity: 91.92%
BLUE Revenue Forecast
BLUE EPS Forecast
BLUE FAQs
What is bull’s view on BLUE?
What is bear's view on BLUE?
What is BLUE revenue forecast for next quarter？
BLUE Analyst's Forecast
Yanan Zhu
Wells Fargo
Hold
Price Target
$3 → $2
Upside
+318.41%
Wells Fargo lowered the firm's price target on Bluebird Bio to $2 from $3 and keeps an Equal Weight rating on the shares. The firm still thinks LYFGENIA has potential, based on initial momentum in patient starts, and thus sees positive long-term outlook. At the same time, Wells sees significant near-term pressure in addressing cash needs before LYFGENIA sales can contribute meaningfully.